Why is Infinium Pharma falling/rising?

As of 19-Sep, Infinium Pharmachem Ltd's stock price is currently at 248.35, reflecting a decrease of 1.6, or 0.64%. The stock has underperformed its sector today by 0.91% and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 0.90%, and it has seen a significant drop of 17.19% year-to-date. However, there has been a notable increase in investor participation, with delivery volume rising by 150% against the 5-day average, indicating some interest despite the overall negative performance. There are no specific positive or negative factors provided that could further explain the stock's recent movement.
In the broader market context, the Sensex has performed positively, gaining 0.85% over the past week and 1.39% over the past month, contrasting sharply with Infinium's declines. The stock's year-to-date performance of -17.19% also significantly lags behind the Sensex's gain of 7.11% in the same period. This underperformance relative to the benchmark suggests that investor sentiment towards Infinium is weak, particularly as the broader market shows resilience and growth.